APE1 may influence CD4+ naive T cells on recurrence free survival in early stage NSCLC. Li Y, Zhao X, Xiao H, Yang B, et al. BMC Cancer 2021;21:233.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Li Y, Zhao X, Xiao H, Yang B, et al. APE1 may influence CD4+ naive T cells on recurrence free survival in early stage NSCLC. BMC Cancer 2021;21:233.
PMID: 33676448